Goal-focused Emotion-Regulation Therapy for young adult survivors of testicular cancer: Feasibility of a behavioral intervention.
Michael A Hoyt, Christian J Nelson
https://pubmed.ncbi.nlm.nih.gov/32913918/Actively Recruiting
Led by University of California, Irvine · Updated on 2025-05-01
250
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a new behavioral intervention called Goal-focused Emotion-Regulation Therapy GET aimed at reducing distress, improving emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult men diagnosed with testicular cancer. This randomized controlled trial compares GET to Individual Supportive Listening ISL to understand their effects on psychological and biological outcomes. The study focuses on young adults aged 18 to 39 who have completed chemotherapy and experience distress related to their cancer. Participants will be randomly assigned to receive either six sessions of GET or ISL over eight weeks. GET helps patients identify meaningful personal goals, refine them, and develop strategies to overcome obstacles while improving emotional regulation and sense of purpose. ISL provides supportive, non-directive therapy focused on listening and encouraging expression of thoughts and feelings. Both interventions are delivered individually via an interactive video platform to improve access. During the study, participants will complete assessments at baseline, immediately after treatment, and at three- and six-month follow-ups. These include questionnaires measuring depression, anxiety, emotion regulation, goal navigation, career confusion, and spiritual well-being. Researchers will also collect biological samples to measure stress hormones and inflammatory markers. The study aims to evaluate the feasibility, acceptability, and effects of these interventions on psychological distress and biological stress indicators in young adult testicular cancer survivors.
CONDITIONS
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
M
Michael A Hoyt, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Irvine
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | GET Therapy | Supportive Listening |
|---|---|---|
| What it is | A structured behavioral intervention focusing on identifying and refining personally meaningful goals, developing goal navigation strategies, and enhancing emotion regulation through skill-based sessions. Designed to improve self-regulation and psychological adaptation after cancer treatment. | A non-directive supportive therapy delivered individually, offering attentive listening and facilitating participants’ expression of thoughts and feelings. Reinforces coping through empathy and discussion to bolster resilience and self-esteem. |
| Role in trial | Experimental intervention arm aiming to reduce emotional distress and improve psychosocial outcomes for young adult testicular cancer survivors. | Active comparator arm providing standard supportive care without structured goal-focused technique for psycho-oncological research control. |
| Primary use | Enhancing emotion regulation, goal navigation, and adaptive coping for distress reduction in young cancer survivors. | Providing supportive listening and emotional validation without structured cognitive or behavioral tasks. |
| How it is given or performed | GET is delivered individually in structured sessions, focusing on goal identification, planning, and interactive skill practice. Sessions are carried out over an 8-week intervention period with additional follow-up assessments. | ISL is delivered individually and matched in session frequency and duration to GET, focusing on providing consistent empathetic listening and reinforcing participant coping. |
| Important limitations | GET’s current evidence is primarily from small pilot and single-center studies, with ongoing trials needed to confirm broader generalizability and long-term clinical impact for diverse cancer survivor populations. | ISL controls for time and supportive attention but does not directly teach goal navigation or emotion regulation strategies. Efficacy for fostering meaningful behavioral change is unproven for this method alone in young cancer survivors. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 8 weeks
Participants receive either the Goal-Focused Emotion-Regulation Therapy (GET) or Individual Supportive Listening (ISL) over 6 sessions to help manage distress and improve emotional regulation after testicular cancer treatment.
6 sessions delivered via an interactive video platform
Duration - Up to 6 months post-intervention
Participants are monitored to assess the lasting effects of the intervention on psychological distress, biobehavioral indicators, and goal navigation.
2 follow-up assessments at 3 months and 6 months post-intervention
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Michael A Hoyt, Christian J Nelson
https://pubmed.ncbi.nlm.nih.gov/32913918/Michael A Hoyt, Ashley Wei-Ting Wang, Sean J Ryan...
https://pubmed.ncbi.nlm.nih.gov/32290859/Michael A Hoyt, Ashley W Wang, Elizabeth C Breen...
https://pubmed.ncbi.nlm.nih.gov/34514890/University of California, Irvine
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborating Sponsor